Author:
Yang Shuang-shuang,Zhang Rui,Wang Gang,Zhang Yong-fang
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Cognitive Neuroscience,Clinical Neurology
Reference39 articles.
1. Xu K, Dai XL, Huang HC, Jiang ZF. Targeting HDACs: a promising therapy for Alzheimer's disease. Oxidative Med Cell Longev. 2011;2011:143269.
2. Zuo L, Hemmelgarn BT, Chuang CC, Best TM. The role of Oxidative stress-induced epigenetic alterations in Amyloid-beta production in Alzheimer's disease. Oxidative Med Cell Longev. 2015;2015:604658.
3. Li X, Bao X, Wang R. Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (review). Mol Med Rep. 2016;14(2):1043–53.
4. Liu RT, Zou LB, Lu QJ. Liquiritigenin inhibits Abeta(25-35)-induced neurotoxicity and secretion of Abeta(1-40) in rat hippocampal neurons. Acta Pharmacol Sin. 2009;30(7):899–906.
5. Fischer A. Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue? Neuropharmacology. 2014;80:95–102.
Cited by
121 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献